AGENUS INC Interest Expense
AGENUS INC (AGEN) reported Interest Expense of $565.52 thousand for the 3-month period ending 2015-06-30, per its 10-Q filed 2015-08-03.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2015-08-03
- AGENUS INC interest expense for the quarter ending 2015-06-30 was $565.52K, a 90.97% increase year-over-year.
- AGENUS INC interest expense for the quarter ending 2015-03-31 was $396.86K, a 11.54% increase year-over-year.
- AGENUS INC interest expense for the quarter ending 2014-12-31 was $299.61K, a 15.22% decline year-over-year.
- AGENUS INC interest expense for the quarter ending 2014-09-30 was $310.08K, a 10.65% decline year-over-year.
- AGENUS INC interest expense for fiscal 2014 was $1.26M, a 47.86% decline from fiscal 2013.
- AGENUS INC interest expense for fiscal 2013 was $2.42M, a 48.46% decline from fiscal 2012.
- AGENUS INC interest expense for fiscal 2012 was $4.69M, a 11.51% increase from fiscal 2011.
- AGENUS INC interest expense for fiscal 2011 was $4.21M, a 13.58% decline from fiscal 2010.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2015-06-30 | $565.52K 10-Q · filed 2015-08-03 | $962.38K 10-Q · filed 2015-08-03 | $1.26M derived: sum of 3 quarters · filed 2015-08-03 | $1.57M derived: sum of 4 quarters · filed 2015-08-03 | ||||
| 2015-03-31 | $396.86K 10-Q · filed 2015-05-01 | $696.47K derived: sum of 2 quarters · filed 2015-05-01 | $1.01M derived: sum of 3 quarters · filed 2015-05-01 | $1.30M derived: sum of 4 quarters · filed 2015-08-03 | ||||
| 2014-12-31 | $299.61K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $609.69K derived: sum of 2 quarters · filed 2015-03-16 | $905.82K derived: sum of 3 quarters · filed 2015-08-03 | $1.26M 10-K · filed 2015-03-16 | ||||
| 2014-09-30 | $310.08K 10-Q · filed 2014-10-31 | $606.21K derived: sum of 2 quarters · filed 2015-08-03 | $962.01K 10-Q · filed 2014-10-31 | $1.32M derived: sum of 4 quarters · filed 2015-08-03 | ||||
| 2014-06-30 | $296.13K 10-Q · filed 2015-08-03 | $651.93K 10-Q · filed 2015-08-03 | $1.01M derived: sum of 3 quarters · filed 2015-08-03 | $1.35M derived: sum of 4 quarters · filed 2015-08-03 | ||||
| 2014-03-31 | $355.81K 10-Q · filed 2015-05-01 | $709.20K derived: sum of 2 quarters · filed 2015-05-01 | $1.06M derived: sum of 3 quarters · filed 2015-05-01 | $1.55M derived: sum of 4 quarters · filed 2015-05-01 | ||||
| 2013-12-31 | $353.39K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $700.41K derived: sum of 2 quarters · filed 2015-03-16 | $1.19M derived: sum of 3 quarters · filed 2015-03-16 | $2.42M 10-K · filed 2015-03-16 | $2.43M 10-K · filed 2014-03-07 | |||
| 2013-09-30 | $347.02K 10-Q · filed 2014-10-31 | -$347.02K 10-Q · filed 2013-11-08 | $837.71K derived: sum of 2 quarters · filed 2014-10-31 | $2.07M 10-Q · filed 2014-10-31 | -$2.07M 10-Q · filed 2013-11-08 | $10.24M derived: sum of 4 quarters · filed 2015-03-16 | ||
| 2013-06-30 | $490.68K 10-Q · filed 2014-08-01 | -$490.68K 10-Q · filed 2013-08-09 | $1.72M 10-Q · filed 2014-08-01 | -$1.72M 10-Q · filed 2013-08-09 | $9.90M derived: sum of 3 quarters · filed 2015-03-16 | $8.71M derived: sum of 4 quarters · filed 2015-03-16 | ||
| 2013-03-31 | $1.23M 10-Q · filed 2014-05-09 | -$1.23M 10-Q · filed 2013-05-10 | $9.41M derived: sum of 2 quarters · filed 2015-03-16 | $8.22M derived: sum of 3 quarters · filed 2015-03-16 | $7.06M derived: sum of 4 quarters · filed 2015-03-16 | |||
| 2012-12-31 | $8.18M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $6.99M derived: sum of 2 quarters · filed 2015-03-16 | $5.84M derived: sum of 3 quarters · filed 2015-03-16 | $4.69M 10-K · filed 2015-03-16 | $4.72M 10-K · filed 2013-03-18 | |||
| 2012-09-30 | -$1.19M 10-Q · filed 2013-11-08 | $1.19M 10-Q · filed 2012-11-07 | -$2.34M derived: sum of 2 quarters · filed 2013-11-08 | -$3.48M 10-Q · filed 2013-11-08 | $3.48M 10-Q · filed 2012-11-07 | -$2.36M derived: sum of 4 quarters · filed 2014-03-07 | ||
| 2012-06-30 | -$1.15M 10-Q · filed 2013-08-09 | $1.15M 10-Q · filed 2012-08-08 | -$2.29M 10-Q · filed 2013-08-09 | $2.29M 10-Q · filed 2012-08-08 | -$1.17M derived: sum of 3 quarters · filed 2014-03-07 | -$78.61K derived: sum of 4 quarters · filed 2014-03-07 | ||
| 2012-03-31 | -$1.14M 10-Q · filed 2013-05-10 | $1.14M 10-Q · filed 2012-05-09 | -$20.25K derived: sum of 2 quarters · filed 2014-03-07 | $1.07M derived: sum of 3 quarters · filed 2014-03-07 | $2.12M derived: sum of 4 quarters · filed 2014-03-07 | |||
| 2011-12-31 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $2.21M derived: sum of 2 quarters · filed 2014-03-07 | $3.26M derived: sum of 3 quarters · filed 2014-03-07 | $4.21M 10-K · filed 2014-03-07 | ||||
| 2011-09-30 | $1.09M 10-Q · filed 2012-11-07 | $2.14M derived: sum of 2 quarters · filed 2012-11-07 | $3.09M 10-Q · filed 2012-11-07 | $4.30M derived: sum of 4 quarters · filed 2013-03-18 | ||||
| 2011-06-30 | $1.05M 10-Q · filed 2012-08-08 | $1.05M 10-Q · filed 2011-08-05 | $2.00M 10-Q · filed 2012-08-08 | $2.01M 10-Q · filed 2011-08-05 | $3.21M derived: sum of 3 quarters · filed 2013-03-18 | $4.43M derived: sum of 4 quarters · filed 2013-03-18 | ||
| 2011-03-31 | $948.20K 10-Q · filed 2012-05-09 | $2.16M derived: sum of 2 quarters · filed 2013-03-18 | $3.38M derived: sum of 3 quarters · filed 2013-03-18 | $4.60M derived: sum of 4 quarters · filed 2013-03-18 | ||||
| 2010-12-31 | $1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $2.44M derived: sum of 2 quarters · filed 2013-03-18 | $3.65M derived: sum of 3 quarters · filed 2013-03-18 | $4.87M 10-K · filed 2013-03-18 | ||||
| 2010-09-30 | $1.23M 10-Q · filed 2011-11-04 | $2.44M derived: sum of 2 quarters · filed 2011-11-04 | $3.66M 10-Q · filed 2011-11-04 | |||||
| 2010-06-30 | $1.21M 10-Q · filed 2011-08-05 | $2.45M 10-Q · filed 2011-08-05 | ||||||
| 2009-12-31 | $5.34M 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |